Strategy of genetic shielding of blood cells helps eradicate blood cancer
HQ Team July 18, 2024: In a reversal strategy in the war against cancer, researchers are now aiming to genetically cloak healthy cells.
Drugs
Health
Medical
Drugs
Health
Pharma
Pfizer’s blood cancer trial data shows survival of more than 2 years
Pfizer Inc.,’s investigational drug for blood cancer, Elrexfio, has shown an overall survival rate of 24.6 months in a single-arm trial, according to.
Drugs
Health
Pharma
Genetic factors may help predict loss of X chromosome in older women
Researchers co-led by the US-based National Cancer Institute have found genetic variants in women that may play a role in promoting abnormal blood.
Drugs
Health
Pharma
GSK’s blood cancer test drug halves risk of disease progression: Data
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a.
Drugs
Health
Pharma
Johnson & Johnson’s blood cancer medicine cleared for bi-weekly use
HQ Team February 21, 2024: Johnson & Johnson announced that USFDA had approved a bi-weekly dose of its blood cancer therapy Tecvayli. The regulatory.
Drugs
Health
Pharma
Gilead Sciences puts last-stage blood cancer trials on hold after FDA order
HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.
Drugs
Health
Pharma
Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio
HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss.
Drugs
Health
Pharma
Eli Lilly’s drug gets second FDA nod for treating blood cancer in adults
HQ Team December 4, 2023: Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood.
Drugs
Health
Pharma
US scientists zero in on single blood cancer therapy in animal studies
HQ Team September 28, 2023: US scientists have honed in on a single chimeric antigen receptor T-cell (CAR T) therapy to cure all.
Drugs
Health
Pharma
EMA recommends stopping sale of GSK’s blood cancer drug in EU
The European Medicines Agency has recommended the stoppage of conditional marketing authorisation for GSK’s Blenrep (belantamab mafodotin), a medicine used to treat cancer of.